Fundraising Fox
C4 Imaging
Bellaire, US · Texas LLC
Find your way into C4 Imaging
Sign up to see every warm intro you have to C4 Imaging
- Paths you didn't know you had: your email and LinkedIn already hold routes to the C4 Imaging team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
C4 Imaging develops the SIRIUS MRI Marker, a device for precise localization of implanted LDR seeds in MRI imaging to support post-implant quality assurance in brachytherapy treatments. The product helps ensure accurate treatment delivery and protects critical anatomical structures during radiation therapy procedures.
Founders & leadership
AB
Andrew BrightPresident & Board memberAndrew Bright has held executive leadership roles in medical device and life sciences for 30 years, including as President and CEO of C4 Imaging and at Oncura (acquired by GE Healthcare), with expertise in regulatory affairs, sales strategy, and commercial operations across multiple therapeutic categories.
Board
HM
Harry MaziarBoard director
SJ
Steven J. FrankFounder
JS
Jeff SeaveyBoard director
SS
Steven SheldonBoard director
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 3 rounds · 2016–2024
▶$1.5MraisedJul 2024 · 43 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJul 2024 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. FrankExecutive Officer
- Jeff SeaveyDirector
- Harry MaziarDirector
- Steven SheldonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Placement agents
- NA
- First sale
- Feb 2024
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$1.2MraisedJun 2018 · 45 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJun 2018 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven J. FrankExecutive Officer, Director
- Andrew BrightExecutive Officer
- Steven SheldonDirector
- Harry MaziarDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jun 2018
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
▶$1.1MraisedOct 2016 · 51 investors · BiotechnologyRule 506(b)
▶$1.1MraisedOct 2016 · 51 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew BrightExecutive Officer
- Harry MaziarDirector
- Steven SheldonDirector
- Steven J. FrankExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Proceeds to insiders
- $50K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
GenhealthGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
ItnonlineImaging Technology News is a trade publication that reaches over 34,000 radiology, radiation oncology, women's health, and nuclear medicine professionals with editorial content and product comparison tools. The publication serves as a primary resource for healthcare technology purchasing decisions within medical imaging specialties.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
Buoy HealthBuoy Health offers an AI-based symptom checker that asks users questions to help identify possible health issues and guides them toward appropriate care, products, or providers. It also publishes health content reviewed by clinicians such as doctors, nurses, and therapists.
Companies working in the same space as C4 Imaging.
In the news
Frequently asked questions
- What does C4 Imaging do?
- C4 Imaging develops the SIRIUS MRI Marker, a device for precise localization of implanted LDR seeds in MRI imaging to support post-implant quality assurance in brachytherapy treatments. The product helps ensure accurate treatment delivery and protects critical anatomical structures during radiation therapy procedures.
- How much funding has C4 Imaging raised?
- C4 Imaging has disclosed $3.8M raised across 3 rounds.
- Where is C4 Imaging headquartered?
- C4 Imaging is headquartered in Bellaire, US.